Clinical Trial Update: DEB-TACE+HAIC vs. HAIC for Large HCC [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing DEB-TACE+HAIC versus HAIC for unresectable hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DEB-TACE+HAIC
• HAIC (hepatic artery infusion chemotherapy)

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Unresectable Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN